Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Suvi Koota"'
Autor:
Pia Leppänen, Ivana Kholová, Anssi J Mähönen, Kari Airenne, Suvi Koota, Hannu Mansukoski, Johanna Närväinen, Maria Wirzenius, Leena Alhonen, Juhani Jänne, Kari Alitalo, Seppo Ylä-Herttuala
Publikováno v:
PLoS ONE, Vol 1, p e13 (2006)
We have generated a transgenic mouse where hVEGF-A(165) expression has been silenced with loxP-STOP fragment, and we used this model to study the effects of hVEGF-A(165) over-expression in mice after systemic adenovirus mediated Cre-gene transfer. Un
Externí odkaz:
https://doaj.org/article/b3e430171ec14f14a0e0055676d8a8ae
Autor:
Ulf Eriksson, Suvi Koota, Kari Alitalo, Jonna Koponen, Seppo Ylä-Herttuala, Christina Fieber, Ivana Kholová, Pia Leppänen
Publikováno v:
Circulation. 112:1347-1352
Background— The role of vascular endothelial growth factors (VEGFs) in large arteries has been proposed to be either vasculoprotective or proatherogenic. Because VEGF family members are used for human therapy, it is important to know whether they c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4decf5b43672ddaf03e0f24e0869c4bf
https://doi.org/10.1161/circulationaha.105.534107
https://doi.org/10.1161/circulationaha.105.534107
Autor:
Juhani Jänne, Eija Pirinen, Mikko I. Kettunen, Esa Hohtola, Teemu Kuulasmaa, Antti Virkamäki, Paula Itkonen, Maija Tusa, Seppo Ylä-Herttuala, Jyrki Parkkinen, J. Kalervo Hiltunen, Kirsi Niiranen, Susanna Boman, Anna-Liisa Levonen, Szabolcs Fatrai, Ulf Smith, Joanna Skommer, Markku Laakso, Leena Alhonen, Emilia Kansanen, Marko Pietilä, Suvi Koota, Sami Heikkinen
Peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) is an attractive candidate gene for type 2 diabetes, as genes of the oxidative phosphorylation (OXPHOS) pathway are coordinatively downregulated by reduced expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b866fedcc54c88e16af8b7e2bd617db8
https://europepmc.org/articles/PMC1951486/
https://europepmc.org/articles/PMC1951486/
Autor:
Suvi Koota, Johanna Närväinen, Pia Leppänen, Ivana Kholová, Petra Korpisalo, Nina Kaskenpää, Martin Kavec, Seppo Ylä-Herttuala, Tuomas T. Rissanen, Thierry Hazes, Olli Gröhn
Publikováno v:
Human gene therapy. 18(3)
We evaluated the therapeutic potential of adenovirus (Ad)-mediated human vascular endothelial growth factor-D (hVEGF-D) gene delivery in mice. Hind limbs of hypercholesterolemic mice ( n = 120) were injected with AdhVEGF-D, AdhVEGF-A, control AdLacZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82514b24da096bcd0b4f457f2b74be02
https://pubmed.ncbi.nlm.nih.gov/17362136
https://pubmed.ncbi.nlm.nih.gov/17362136
Autor:
Tero Vatanen, Pia Leppänen, Seppo Ylä-Herttuala, Petri I. Mäkinen, Suvi Koota, Mikko P. Turunen, Juulia Enback
Publikováno v:
Molecular Therapy. 11:S16
Apolipoprotein B-100 (ApoB-100) is an essential component low density lipoprotein (LDL), transporting cholesterol in circulation and acting as a ligand for the LDL-receptor. In atherosclerotic mice the reduction of ApoB-100 expression leads to the re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d7652efb77a598e8e72f49016654ac7
https://doi.org/10.1016/j.ymthe.2005.06.043
https://doi.org/10.1016/j.ymthe.2005.06.043
Autor:
Ivana Kholová, Suvi Koota, Nina Kaskenpää, Pia Leppänen, Johanna Närväinen, Martin Kavec, Tuomas T. Rissanen, Thierry Hazes, Petra Korpisalo, Olli Gröhn, Seppo Ylä-Herttuala
Publikováno v:
Human Gene Therapy; Mar2007, Vol. 18 Issue 3, p232-244, 13p